
Does Intel Stock Have Room to Grow?
Intel Corporation (NASDAQ:INTC)’s recent innovations, Xeon 6 SoC and Xeon®…
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
Income Statement | ||||||
Revenue | $18.4B | $20.5B | $22.6B | $5.8B | $6.4B | |
Gross Profit | $11.6B | $13.1B | $14.4B | $3.7B | $4.2B | |
Operating Income | $3.1B | $3.9B | $4.7B | $1.3B | $1.6B | |
EBITDA | $4.1B | $5B | $5.7B | $1.5B | $1.8B | |
Diluted EPS | $6.17 | $8.25 | $7.76 | $2.98 | $1.41 |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Balance Sheet | ||||||
Current Assets | $9.7B | $10B | $10.3B | $12.5B | $14.8B | |
Total Assets | $34.3B | $34.6B | $36.9B | $39.9B | $43B | |
Current Liabilities | $5B | $4.5B | $6.3B | $7.9B | $7.6B | |
Total Liabilities | $21.2B | $19.8B | $20.3B | $21.3B | $22.3B | |
Total Equity | $13.1B | $14.9B | $16.6B | $18.6B | $20.6B | |
Total Debt | $14B | $12.5B | $13B | $13B | $13.6B |
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
Cash Flow Statement | ||||||
Cash Flow Operations | $2.6B | $3.7B | $4.2B | $1.5B | $1.9B | |
Cash From Investing | -$2.9B | -$962M | -$3B | -$152M | -$303M | |
Cash From Financing | -$749M | -$1.6B | -$525M | -$286M | -$1.8B | |
Free Cash Flow | $2B | $3.1B | $3.5B | $1.4B | $1.7B |
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.
In the current month, SYK has received 13 Buy ratings 9 Hold ratings, and 1 Sell ratings. The SYK average analyst price target in the past 3 months is $423.36.
According to analysts, the consensus estimate is that Stryker share price will rise to $423.36 per share over the next 12 months.
Analysts are divided on their view about Stryker share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Stryker is a Sell and believe this share price will drop from its current level to $276.00.
The price target for Stryker over the next 1-year time period is forecast to be $423.36 according to 23 Wall Street analysts, 13 of them rate the stock a Buy, 1 rates the stock a Sell, and 9 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for Stryker is a Buy. 13 of 23 analysts rate the stock a Buy at this time.
You can purchase shares of Stryker via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Stryker shares.
Stryker was last trading at $365.30 per share. This represents the most recent stock quote for Stryker. Yesterday, Stryker closed at $379.30 per share.
In order to purchase Stryker stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
Intel Corporation (NASDAQ:INTC)’s recent innovations, Xeon 6 SoC and Xeon®…
For many years, Walmart (NYSE:WMT) has been the world’s largest…
The AI race has heated up significantly but returns on…
Market Cap: $3.6T
P/E Ratio: 39x
Market Cap: $2.8T
P/E Ratio: 32x
Market Cap: $2.6T
P/E Ratio: 36x
Willdan Group [WLDN] is down 3.97% over the past day.
Guardant Health [GH] is up 8.39% over the past day.
Pro-Dex [PDEX] is up 17.54% over the past day.